Viewing nowCombinationExcombi Tablet 10/160 mg
Amlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.

MFDS item code 201309092 · Approved 2013.08.30 · Insurance code 671805610
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of amlodipine or valsartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to the active ingredient or similar compounds, women who are pregnant or breastfeeding, and patients with severe kidney or liver disease should not take this medication. Patients with sodium or fluid depletion, patients with hyperkalemia, patients with renal artery stenosis, and patients who have recently undergone kidney transplantation require special caution when taking this medication, and close monitoring by healthcare professionals is necessary. Since this medication lowers blood pressure, emergency measures are required if symptoms of hypotension occur, such as laying the patient down and administering saline if necessary. This medication may cause side effects such as headache, dizziness, swelling, fatigue, and skin rash, and if symptoms are severe or persistent, patients should consult their healthcare provider. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. This medication can interact with other antihypertensive drugs, potassium supplements, diuretics, and certain anti-inflammatory drugs (NSAIDs), so patients should inform their healthcare provider of any other medications they are taking. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are also advised to avoid it. It is not recommended for children under 18 years of age as the safety and efficacy of this medication have not been adequately established in pediatric patients. Severe hypotension or cardiac dysfunction may occur in cases of overdose, so it is crucial to adhere to the prescribed dosage and inform the healthcare provider of any unusual symptoms.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbances, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, diaphoresis, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, bowel angioedema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disturbance, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, Stevens-Johnson syndrome, itching, peripheral edema, hypotension
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius to safely preserve the effectiveness of the medication.
Bright yellow oval film-coated tablet
For domestic use: 30 tablets (10 tablets/PTP X 3), for export: 30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.